Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

XST-14

🥰Excellent
TargetMol
Catalog No. T60604Cas No. 2607143-50-8

XST-14 is a competitive and specific inhibitor of ULK1 (IC50: 26.6 nM).XST-14 blocks autophagy by inhibiting the phosphorylation of ULK1 downstream substrates.XST-14 induces apoptosis and inhibits the growth of HCC cells.

XST-14

XST-14

🥰Excellent
TargetMol
Purity: 99.68%
Catalog No. T60604Cas No. 2607143-50-8
XST-14 is a competitive and specific inhibitor of ULK1 (IC50: 26.6 nM).XST-14 blocks autophagy by inhibiting the phosphorylation of ULK1 downstream substrates.XST-14 induces apoptosis and inhibits the growth of HCC cells.
Pack SizePriceAvailabilityQuantity
1 mg$51In Stock
5 mg$119In Stock
10 mg$182In Stock
25 mg$328In Stock
50 mg$496In Stock
1 mL x 10 mM (in DMSO)$133In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "XST-14"

Select Batch
Purity:99.68%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
XST-14 is a competitive and specific inhibitor of ULK1 (IC50: 26.6 nM).XST-14 blocks autophagy by inhibiting the phosphorylation of ULK1 downstream substrates.XST-14 induces apoptosis and inhibits the growth of HCC cells.
Targets&IC50
ULK1:26.6 nM
In vitro
Treatment of HepG2 cells with XST-14 (5 μM) alone or in combination with sorafenib (5 μM) for 24 hours showed a synergistic effect, indicating that XST-14 in combination with sorafenib can inhibit HCC in vitro[1].
In vivo
BALB/c mice were treated with XST-14 (30 mg/kg, IP, every other day), sorafenib (30 mg/kg, P.O), or a combination of sorafenib (30 mg/kg, P.O) and XST-14 (30 mg/kg, IP) for 2 weeks. The results indicate that XST-14 exhibits favorable drug metabolism and pharmacokinetic (DMPK) properties, with no significant toxicity observed on liver/kidney function or body weight.
Chemical Properties
Molecular Weight291.34
FormulaC16H21NO4
Cas No.2607143-50-8
SmilesCOC(=O)c1cc2c(OC(C)C)cc(OC(C)C)cc2[nH]1
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 80 mg/mL (274.59 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.4324 mL17.1621 mL34.3242 mL171.6208 mL
5 mM0.6865 mL3.4324 mL6.8648 mL34.3242 mL
10 mM0.3432 mL1.7162 mL3.4324 mL17.1621 mL
20 mM0.1716 mL0.8581 mL1.7162 mL8.5810 mL
50 mM0.0686 mL0.3432 mL0.6865 mL3.4324 mL
100 mM0.0343 mL0.1716 mL0.3432 mL1.7162 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy XST-14 | purchase XST-14 | XST-14 cost | order XST-14 | XST-14 chemical structure | XST-14 in vivo | XST-14 in vitro | XST-14 formula | XST-14 molecular weight